Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us nowIn 2021, oncology applications accounted for over 22.5 percent of the global targeted sequencing market, while applications for infectious diseases followed with a 16.4 percent market share. By 2032, the share taken up by oncology was forecast to increase to almost 25 percent.
You only have access to basic statistics.
This statistic is not included in your account.
Business Solutions including all features.
Overview
Sales
Trade
Leading manufacturers
Research and development expenses
Approved products and patents